![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 1855O
GW Pharmaceuticals PLC
02 November 2016
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely associated --- ---------------------------------------------------------------------------- a. Name Mr Justin Gover --- ------------------------------ -------------------------------------------- 2. Reason for the notification --- ---------------------------------------------------------------------------- a. Position/status Chief Executive Officer --- ------------------------------ -------------------------------------------- b. Initial Initial notification notification /Amendment --- ------------------------------ -------------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------------------------- a. Name GW Pharmaceuticals PLC --- ------------------------------ -------------------------------------------- b. LEI --- ------------------------------ -------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------------------- a. Description of the Ordinary shares of 0.1p each ISIN: Financial GB0030544687 instrument, Restricted American Depositary type of Shares: ISIN: US36197T1372 instrument Identification code --- ------------------------------ -------------------------------------------- b. Nature of Conversion of 2,513,748 Ordinary the transaction shares into 209,479 Nasdaq listed Restricted ADRs (12 to 1 Conversion ratio) --- ------------------------------ -------------------------------------------- c. Price(s) Price(s) Volume(s) and volume(s) - 209,479 ADSs issued upon conversion of 2,513,748 Ordinary shares --------- ---------- ------------------- --- ------------------------------ -------------------------------------------- d. Aggregated information * Aggregated volume n/a * Price --- ------------------------------ -------------------------------------------- e. Date of 2 November 2016 the transaction --- ------------------------------ -------------------------------------------- f. Place of New York the transaction --- ------------------------------ --------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFIDLSLFIIR
(END) Dow Jones Newswires
November 02, 2016 13:05 ET (17:05 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions